| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ISRG | Common Stock | Options Exercise | $37,805 | +156 | +20% | $242.34 | 918 | 22 Oct 2021 | Direct | F1, F2 |
| transaction | ISRG | Common Stock | Sale | $52,994 | -156 | -17% | $339.71 | 762 | 22 Oct 2021 | Direct | F1, F2, F3 |
| transaction | ISRG | Common Stock | Options Exercise | $27,766 | +156 | +20% | $177.99 | 918 | 22 Oct 2021 | Direct | F1, F2 |
| transaction | ISRG | Common Stock | Sale | $52,986 | -156 | -17% | $339.66 | 762 | 22 Oct 2021 | Direct | F1, F2, F4 |
| transaction | ISRG | Common Stock | Options Exercise | $45,488 | +273 | +36% | $166.62 | 1,035 | 22 Oct 2021 | Direct | F1, F2 |
| transaction | ISRG | Common Stock | Sale | $92,726 | -273 | -26% | $339.66 | 762 | 22 Oct 2021 | Direct | F1, F2, F4 |
| transaction | ISRG | Common Stock | Options Exercise | $49,913 | +273 | +36% | $182.83 | 1,035 | 22 Oct 2021 | Direct | F1, F2 |
| transaction | ISRG | Common Stock | Sale | $92,726 | -273 | -26% | $339.66 | 762 | 22 Oct 2021 | Direct | F1, F2, F4 |
| transaction | ISRG | Common Stock | Options Exercise | $55,936 | +321 | +42% | $174.26 | 1,083 | 22 Oct 2021 | Direct | F1, F2 |
| transaction | ISRG | Common Stock | Sale | $109,029 | -321 | -30% | $339.66 | 762 | 22 Oct 2021 | Direct | F1, F2, F4 |
| transaction | ISRG | Common Stock | Options Exercise | $45,204 | +324 | +43% | $139.52 | 1,086 | 22 Oct 2021 | Direct | F1, F2 |
| transaction | ISRG | Common Stock | Sale | $110,048 | -324 | -30% | $339.66 | 762 | 22 Oct 2021 | Direct | F1, F2, F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ISRG | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -324 | -43% | $0.000000 | 432 | 22 Oct 2021 | Common Stock | 324 | $139.52 | Direct | F1, F2, F5 |
| transaction | ISRG | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -273 | -16% | $0.000000 | 1,449 | 22 Oct 2021 | Common Stock | 273 | $166.62 | Direct | F1, F2, F6 |
| transaction | ISRG | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -321 | -43% | $0.000000 | 432 | 22 Oct 2021 | Common Stock | 321 | $174.26 | Direct | F1, F2, F6 |
| transaction | ISRG | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -156 | -9.3% | $0.000000 | 1,521 | 22 Oct 2021 | Common Stock | 156 | $177.99 | Direct | F1, F2, F5 |
| transaction | ISRG | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -273 | -16% | $0.000000 | 1,449 | 22 Oct 2021 | Common Stock | 273 | $182.83 | Direct | F1, F2, F7 |
| transaction | ISRG | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -156 | -9.3% | $0.000000 | 1,515 | 22 Oct 2021 | Common Stock | 156 | $242.34 | Direct | F1, F2, F6 |
| Id | Content |
|---|---|
| F1 | These shares were exercised and sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 8, 2021. |
| F2 | On October 5, 2021, the common stock and equity grants of Intuitive Surgical split 3-for-1, resulting in the reporting person's ownership of the company's stock and equity grants to increase (for every one share owned or granted, 2 additional shares were issued) and the exercise price of stock option grants to decrease to 1/3rd of the original grant price. |
| F3 | The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $338.64 to $341.03 as follows: 20 shares sold at $338.64 to $338.99; 106 shares sold at $339.06 to $339.98; 30 shares sold at $340.04 to $341.03. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| F4 | The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $338.47 to $341.34 as follows:179 shares sold at $338.47 to $338.99; 866 shares sold at $339 to $339.99; 280 shares sold at $340.09 to $340.82; 22 shares sold at $341 to $341.34. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| F5 | Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |
| F6 | Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48th one month after the date of grant and 1/48th monthly thereafter. |
| F7 | Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |